GLP-1-class weight-loss drugs can help users shed dozens of pounds, leading to a more active, energized life. One in eight Americans now say they are taking the shots, which first became popularized ...

GLP-1 medications, such as Ozempic, Zepbound and Wegovy, have emerged as a significant advancement in the treatment of various conditions, including Type 2 diabetes, heart ...

For patients with end-stage kidney disease, excess weight can stand between them and a life-saving transplant. Now, researchers at The Ohio State University Wexner Medical Center have found a ...

Recent research has shown how weight-loss and diabetes medications, also known as glucagon-like peptide-1 receptor agonists (GLP-1s), can help with a variety of other conditions. This includes ...

Humans have long dreamed of a cure-all.Subscribe to The Post Most newsletter for the most important and interesting stories ...

SELECT was a large study focused on obesity and cardiovascular disease in people without type 2 diabetes, but it included ...

Wegovy is a Food and Drug Administration-approved weight loss medication for people with obesity or those who are overweight with weight-related health conditions. In recent years, interest in ...

In the United States, 73.6 percent of adults are overweight or obese, with 41.9 percent classified as obese. Excess weight increases the risk of type 2 diabetes, cardiovascular disease, stroke, ...